<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132924/bin/12885_2014_4756_Fig4_HTML.jpg"/> </div> <div class="text-side"> <h1>Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles.</h1> <p>
Correlation between Neu5Gc-GM3 and melanoma cell malignancy. (A) HPTLC separation of gangliosides of two cell clones (2/14 and 2/21) isolated from a single patient. (B) HPTLC separation of Neu5Ac-GM3 and Neu5Gc-GM3 in NHEM-Ad, NHEM-Neo, clone 2/14, and in melanoma cell lines representative of cluster 1 (L6), cluster 2 (L34), cluster 3 (L4). (C) 14 F7 antibody immunostaining of gangliosides separated by HPTLC (NHEM-Ad, NHEM-Neo, L6 representative of cluster 1, L34 representative of cluster 2, L4 representative of cluster 3. (D) Immunohistochemical analysis of cytospin preparations of L6 representative of cluster 1 and L34 representative of cluster 2, stained with 14 F7 antibody. Original magnification, x20 (Axiovert 100). Similar results were obtained for other melanoma cell lines according to the clustering.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/25085576/" target="_blank">25085576</a></p><p>Type: Premalignant/Malignant, Category: Melanocytic</p>
</div> </div></div></body></html>